SILAC
Stable isotope labeling by cell culture (SILAC) is a technique used to study proteomics, metabolic pathways, and cellular biological processes. SILAC involves labeling cellular proteins with amino acids containing stable isotopes during cell culture, allowing for the distinction of labeled proteins from unlabeled ones in mass spectrometry analysis. This method provides a powerful tool for researchers to quantify proteins, examine protein-protein interactions, and investigate functional changes, with important applications in areas such as disease mechanisms, drug development, and biomarker screening. The core principle of SILAC is to incorporate stable isotope-labeled amino acids (such as ^15N or ^13C) into the protein sequences during protein synthesis. Unlike radioactive isotopes, stable isotopes are non-toxic to cells, making SILAC a widely used technique in various cell and organism-based studies. Labeled and unlabeled cells can be compared, and mass spectrometry is used to quantify protein abundance, explore expression differences, post-translational modifications, and their alterations under various physiological or pathological conditions.
SILAC has broad applications, especially in proteomics research, where it is a valuable tool. Protein quantification is central to modern biological studies, but traditional methods are often limited by the need for comparative standards and the inability to handle multiple samples simultaneously. SILAC allows precise protein quantification across different conditions within the same experiment by using isotopically labeled amino acids. When coupled with mass spectrometry, SILAC provides sensitive and efficient detection of protein changes, allowing the extraction of detailed quantitative data from complex biological samples, and aiding in the discovery of cellular processes and mechanisms.
SILAC is not only useful for comparing protein abundance but also for studying post-translational modifications (PTMs), such as phosphorylation, acetylation, and ubiquitination. These modifications play key roles in regulating cellular functions. SILAC enables tracking of specific modified proteins, providing insights into their dynamic changes. When combined with mass spectrometry, SILAC effectively identifies modification sites and patterns, further clarifying their roles in cellular signaling, metabolic regulation, and responses to stimuli.
A major advantage of SILAC is its high-resolution protein quantification. Under various biological conditions, SILAC allows precise differentiation of protein abundance in labeled and unlabeled samples. The relative abundance of proteins can be compared, providing accurate quantitative data and revealing trends in protein changes under different conditions. The use of various stable isotope labeling methods (e.g., ^13C or ^15N) allows researchers to select the optimal labeling strategy for their specific needs, further enhancing the sensitivity and accuracy of the analysis.
Additionally, SILAC excels in multiplex sample analysis. Unlike traditional methods that only allow the comparison of two samples at a time, SILAC enables the comparison of multiple samples in the same mass spectrometry run, supporting high-throughput protein quantification. This makes SILAC essential for high-throughput screening, disease-related protein discovery, and drug target research.
SILAC's application in disease research is particularly significant, especially in cancer, neurodegenerative diseases, and infectious diseases. It provides an efficient means to analyze protein expression patterns during disease progression. By comparing protein differences between healthy and diseased states, SILAC helps identify potential biomarkers and therapeutic targets. For example, changes in specific protein expressions in cancer cells are often closely related to tumor initiation, progression, and metastasis. By quantifying these changes, SILAC reveals the molecular mechanisms of tumor cells, offering new avenues for targeted therapies.
SILAC also plays a crucial role in drug screening and new drug development. By comparing protein changes in cells before and after drug treatment, it helps identify drug targets and mechanisms of action. This is critical for the development of efficient, low-toxicity targeted drugs and for assessing the impact of drugs on cellular metabolism and signaling pathways.
MtoZ Biolabs offers high-quality, one-stop analysis services, providing precise protein quantification to reveal protein changes under different biological conditions and support in-depth studies of disease mechanisms, drug effects, and cellular biological processes.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
